Press release
Generic Oncology Drugs Market is predicted to rise US$ 41.5 Bn by the end of 2031 at a CAGR 6% | PMR
Drivers for the market include the high cost of brand-name cancer drugs, the aging population, and the increasing incidence of cancer. In addition, favorable government regulations, such as generic drug approval processes and reimbursement policies, have also contributed to the growth of the market.
Request For Free Sample Report of "Generic Oncology Drugs Market"@ https://www.persistencemarketresearch.com/samples/25480
Another factor driving the growth of the generic oncology drugs market is the increasing adoption of generic drugs as a cost-effective alternative to brand-name drugs. Many cancer treatments can be expensive, and the use of generic drugs can help to reduce the overall cost of treatment for patients and healthcare systems.
The generic oncology drugs market is also being fueled by advances in technology and manufacturing processes, which are helping to improve the quality and availability of generic drugs. In addition, regulatory changes and the expiration of patents on some brand-name cancer drugs are also contributing to the growth of this market.
Companies
Novartis AG
Pfizer Inc.
GlaxoSmithKline plc
CELGENE CORPORATION
Teva Pharmaceutical Industries Ltd.
Merck & Company, Inc
Aurobindo Pharma.
Hikma Pharmaceuticals PLC
Mylan N.V.
NATCO Pharma Limited.
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/25480
Several key players in the generic oncology drugs market include Teva Pharmaceuticals, Sandoz, and Mylan. These companies offer a range of generic oncology drugs, including chemotherapy agents, targeted therapies, and immunotherapies.
Overall, the generic oncology drugs market is expected to see strong growth in 2022 and beyond, as increasing demand for cost-effective cancer treatments and advances in technology and manufacturing drive market demand.
Competitive Landscape
Key market participants are focusing on mergers & collaborations to increase their geographical presence. Research & development of novel generic oncology drugs is also a prime area of focus for major market players.
In October 2021, Biocon Ltd., an Indian biopharmaceutical firm, announced the expansion of its generic formulations portfolio in the U.S. Expansion was marked by the launch of Everolimus tablets, which are a generic version of Afinitor. The drug was approved by the FDA in February 2021 and was launched commercially in October.
Ayana, an Israel-based company, got approval for its cancer-killing drug from the FDA. Generic drug Doxorubicin-HCI Liposomal Injection will now be available in the U.S.
In October 2021, with the launch of Abiraterone Acetate, Dr. Reddy's Laboratories became the first Indian pharmaceutical firm to launch an anti-cancer drug in China.
More recent developments related to key generic oncology drug manufacturers have been also been tracked by analysts at Persistence Market Research, which will be accessible in the full report.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/25480
Key Segments Covered in Generic Oncology Drugs Industry Research
By Molecule Type
Large Molecules
Small Molecules
By Route of Administration
Oral Generic Oncology Drugs
Parenteral Generic Oncology Drugs
By Distribution Channel
Generic Oncology Drugs from Hospital Pharmacies
Generic Oncology Drugs from Retail Pharmacies
Generic Oncology Drugs from Online Pharmacies
Generic Oncology Drugs from Managed Care Institutions
For More Premium Insights, Check out the Link:
Wound Healing Assessment Market - https://www.prnewswire.com/news-releases/wound-healing-assessment-market-is-expected-to-reach-us-153-8-mn-by-2031--301469550.html
Liquid Embolic Market - https://www.prnewswire.com/news-releases/liquid-embolic-market-is-projected-to-experience-a-noteworthy-8-9-cagr-to-reach-a-market-valuation-of-approximately-us-580-5-mn-by-2031--301467442.html
North America Vet Compounding Pharmacies Market - https://www.prnewswire.com/news-releases/north-america-vet-compounding-pharmacies-market-is-expected-to-increase-from-us-1-1-bn-in-2020-to-over-us-2-7-bn-by-2031--301467339.html
Car T Cell Therapy Market - https://www.prnewswire.com/news-releases/car-t-cell-therapy-market-is-anticipated-to-reach-us-2-8-bn-by-2031--301436943.html
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Oncology Drugs Market is predicted to rise US$ 41.5 Bn by the end of 2031 at a CAGR 6% | PMR here
News-ID: 2914160 • Views: …
More Releases from Persistence Market Research
Aseptic Packaging Market Set to Grow to US$136.5 Bn by 2033 Driven by Rising Foo …
Introduction: Aseptic Packaging Market Overview and Industry Evolution
The aseptic packaging market has emerged as a cornerstone of modern food, beverage, and pharmaceutical preservation systems. As global consumers increasingly seek safe, long-lasting, and convenient packaged products, aseptic packaging solutions have gained substantial importance. This technology allows products to be sterilized separately from packaging materials and filled in a sterile environment, ensuring extended shelf life without refrigeration or preservatives. The rising demand…
Gas-Insulated Transmission Line (GIL) Market Expected to See Growth to US$836.9 …
Introduction: Rising Demand for Advanced Power Transmission Solutions
The global energy landscape is undergoing a major transformation as nations accelerate investments in renewable energy, grid expansion, and reliable electricity distribution networks. With rapid urbanization, industrialization, and digital infrastructure growth, the demand for uninterrupted and efficient power transmission has never been higher. Traditional overhead transmission systems, while widely used, face challenges related to land constraints, environmental exposure, and transmission losses. This has…
Dimethyl Sulfide (DMS) Market Anticipated to Reach US$ 251.2 Mn by 2033, Driven …
Market Overview: Expanding Demand for Dimethyl Sulfide Across Industries
The Dimethyl Sulfide (DMS) market is witnessing consistent growth due to its widespread applications across food processing, pharmaceuticals, agriculture, and chemical manufacturing. Dimethyl sulfide is an organosulfur compound known for its distinctive odor and reactive properties, making it a crucial intermediate in multiple industrial processes. In food and beverage applications, it is valued for flavor enhancement, while in chemical manufacturing, it serves…
Onyx Stone Market to Surge to Reach US$ 1.8 Bn by 2033 Driven by Construction & …
Market Overview: Rising Demand for Premium Natural Stones
The onyx stone market has gained remarkable prominence in recent years, driven by increasing demand for luxury natural stones in architecture, interior décor, and artistic applications. Onyx, known for its translucent appearance and unique veining patterns, has become a preferred choice for premium residential and commercial projects. The material's ability to elevate aesthetic appeal while maintaining durability has attracted designers, architects, and homeowners…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
